Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04407364 · ClinicalTrials.gov registry record
MPM Medical CoMatryx Surgical Bovine Collagen Study
A clinical trial of Surgical Wound, Healed, sponsored by MPM Medical.
- Active
- Registry status
- 72
- Enrollment target
- 1
- Study location
NCT04407364: Active study of Surgical Wound, Healed, sponsored by MPM Medical.
NCT04407364 is a study of Surgical Wound, Healed that is active but no longer recruiting, run by MPM Medical. The registered enrollment target is 72 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04407364, a study of Surgical Wound, Healed, is active but no longer recruiting, sponsored by MPM Medical.
- ACTIVE NOT RECRUITING
- Registry status
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The primary objective is to confirm safety and clinical benefits of the product. This will be assessed by recording the rate of wound healing and incidence and frequency of wound care related complications. Relationship of complications to the product should be specified.
Conditions Studied
Interventions
- DEVICE CoMatryx Surgical Bovine Collagen
Study Locations (1)
Texas
- Texas Center for Joint Replacement - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2020-09-02 |
| Est. Completion | 2025-05-02 |
What the registry record for NCT04407364 still lists
NCT04407364 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 72 participants, a relatively small participant target.
The record links to 1 condition, with Surgical Wound, Healed appearing as the primary indexed condition, and to 1 intervention - of which CoMatryx Surgical Bovine Collagen is the first listed.
NCT04407364 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT04407364 about?
NCT04407364 is a clinical study titled "MPM Medical CoMatryx Surgical Bovine Collagen Study". The objective of this prospective enrollment study is to collect data confirming safety, performance and clinical benefits of the CoMatryx Surgical Collagen powder at a minimum 1-year follow-up and compare it to a historical control group who did not receive the product at the time of surgery. The ...
What is the current status of trial NCT04407364?
This trial is currently active not recruiting. The enrollment target is 72 participants. The study started on 2020-09-02. Estimated completion is 2025-05-02.
What conditions does trial NCT04407364 study?
This clinical trial studies the following conditions: Surgical Wound, Healed.
What interventions are being tested in trial NCT04407364?
The interventions under investigation include: CoMatryx Surgical Bovine Collagen (DEVICE).
Who is sponsoring clinical trial NCT04407364?
This trial is sponsored by MPM Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04407364 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02359253 · 72 participants · NA
Robot Aided Rehabilitation - Intervention
- NCT02962661 · 72 participants · Phase 1
Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines
- NCT03113643 · 72 participants · Phase 1
SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
- NCT03187535 · 72 participants · NA
Effect of TEAS on PONV After Spinal Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI